Headline:
 Time is Brain: Unpad Study Urges Wider Stroke Treatment Access in Indonesia

Every year, millions suffer strokes, with Indonesia facing one of the highest burdens in Asia. A new study by Dr. Lisda Amalia and Putri Qonitah from Universitas Padjadjaran analyzed hyperacute ischemic stroke patients treated with intravenous thrombolysis at Dr. Hasan Sadikin Hospital, Bandung.

The research showed that most patients were elderly and arrived within the critical 4.5-hour window. With timely treatment, 91% avoided complications, and half recovered well—proof that intravenous thrombolysis works in Indonesia.

But there’s a catch: only a handful of hospitals provide this therapy. Many patients still miss their window because of limited awareness, delays in referrals, or lack of infrastructure. The result is avoidable disability and death.

The call is clear: expand thrombolysis services, train health workers to recognize stroke signs, and educate the public that sudden weakness, slurred speech, or facial drooping are medical emergencies.

This effort supports SDG 3 (Health) and SDG 9 (Industry, Innovation, Infrastructure), pushing Indonesia closer to equitable healthcare. By showcasing local success, Unpad strengthens its place in the Times Higher Education Impact Rankings, proving research can save lives when translated into action.